Cargando…
The Extracellular Matrix Influences Ovarian Carcinoma Cells’ Sensitivity to Cisplatinum: A First Step towards Personalized Medicine
The development of personalized therapies for ovarian carcinoma patients is still hampered by several limitations, mainly the difficulty of predicting patients’ responses to chemotherapy in tumor cells isolated from peritoneal fluids. The main reason for the low predictive power of in vitro assays i...
Autores principales: | Balduit, Andrea, Agostinis, Chiara, Mangogna, Alessandro, Maggi, Veronica, Zito, Gabriella, Romano, Federico, Romano, Andrea, Ceccherini, Rita, Grassi, Gabriele, Bonin, Serena, Bonazza, Deborah, Zanconati, Fabrizio, Ricci, Giuseppe, Bulla, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281165/ https://www.ncbi.nlm.nih.gov/pubmed/32392708 http://dx.doi.org/10.3390/cancers12051175 |
Ejemplares similares
-
Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells
por: Balduit, Andrea, et al.
Publicado: (2020) -
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas
por: Mangogna, Alessandro, et al.
Publicado: (2019) -
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
por: Agostinis, Chiara, et al.
Publicado: (2021) -
C1q–HA Matrix Regulates the Local Synthesis of Hyaluronan in Malignant Pleural Mesothelioma by Modulating HAS3 Expression
por: Vidergar, Romana, et al.
Publicado: (2021) -
COVID-19, Pre-Eclampsia, and Complement System
por: Agostinis, Chiara, et al.
Publicado: (2021)